Suchergebnisse - "Davies, Faith E."

PubPharm (346)

1

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib-lenalidomide-dexamethasone for relapsed/refractory multiple myeloma : A pooled analysis from the INSURE study

enthalten in: European journal of haematology | 2024

von Lee, H. | Ramasamy, K. | Macro, M. | +10

2

Retraction : Ku86 Variant Expression and Function in Multiple Myeloma Cells Is Associated with Increased Sensitivity to DNA Damage

enthalten in: Journal of immunology (Baltimore, Md. : 1950) | 2024

von Tai, Y. | Teoh, G. | Lin, B. | +8

RetractionOf: J Immunol. 2000 Dec 1;165(11):6347-55. - PMID 11086072

3

Advanced practice providers in hematology : actionable findings from national paired APP and physician surveys

enthalten in: Blood advances | 2024

von Marshall, A. | Masselink, L. | Kouides, P. | +7

4

Round Table Discussion on Optimal Clinical Trial Design in Precursor Multiple Myeloma

enthalten in: Blood cancer discovery | 2024

von Ghobrial, I. | Gormley, N. | Kumar, S. | +28

5

Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens

enthalten in: Nature cancer | 2023

von Maura, F. | Boyle, E. | Coffey, D. | +34

6

An indirect treatment comparison of efficacy and health-related quality of life following treatment with idecabtagene vicleucel versus belantamab mafodotin in triple-class exposed relapsed/refractory patients with multiple myeloma

enthalten in: Leukemia & lymphoma | 2023

von Rodríguez Otero, P. | Towle, K. | Cope, S. | +11

7

A Meta-Analysis of the Efficacy of Pomalidomide-Based Regimens for the Treatment of Relapsed/Refractory Multiple Myeloma After Lenalidomide Exposure

enthalten in: Clinical lymphoma, myeloma & leukemia | 2023

von Davies, F. | Leleu, X. | Vogel, P. | +3

8

Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Boyle, E. | Blaney, P. | Stoeckle, J. | +25

9

Maintenance lenalidomide in newly diagnosed transplant eligible and non-eligible myeloma patients; profiling second primary malignancies in 4358 patients treated in the Myeloma XI Trial

enthalten in: EClinicalMedicine | 2023

von Jones, J. | Cairns, D. | Menzies, T. | +15

10

The addition of vorinostat to lenalidomide maintenance for patients with newly diagnosed multiple myeloma of all ages : results from 'Myeloma XI', a multicentre, open-label, randomised, phase III trial

enthalten in: British journal of haematology | 2023

von Jenner, M. | Pawlyn, C. | Davies, F. | +16

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[35]